All News

Participants indicated that they would be more likely to accept PrEP-related information if it was recommended by a trusted person.

The drug is the first approved antiviral COVID-19 treatment that could be used across all stages of liver disease.

UB-311 has shown to be well-tolerated with a durable antibody response in a previous phase 1 trial, and new results from a phase 2a study support its continued development.

Cases address malaise and hyperglycemia.

The phase 3 study will advance the safety findings of survodutide reported in the phase 2 study to aid overweight and obesity.

Pharmacists can provide important safety education to patients and health care professionals.

Consumerization of health care solutions is connected to a growing desire of patients to have accessible health care/health data and an individualized care experience.

Belzutifan also demonstrated statistically significant improvements in objective response rate compared to everolimus for advanced renal cell carcinoma.

In the study, investigators incorporated data from electronic health records and social determinants of health into the model to determine the likelihood in delays when starting cancer therapy.

Notably, 65% of the participants experiencing pain at the 2-month follow up were also experiencing pain at their 12-month follow up, suggesting persistent and long-term pain.

During the phase 1b/2 trials, CAR T-cell therapy demonstrated significant and clinical survival benefits.

Protection of T cells from tumor-induced suppression suggests potential for enhancing efficacy of therapies, with plans to initiate a phase 1/2 clinical trial in patients with advanced breast cancer.

Kristin Glezman, PharmD, owner and pharmacist in charge of the independent pharmacy in Denison, Texas, takes pride in caring for the local community.

By embracing collaboration, optimizing work hours, and prioritizing patient care, pharmacy technicians are leading the charge towards an inclusive, technologically advanced, and patient-focused era in pharmaceutical practice.

The drug showed statistically significant and clinically meaningful efficacy results across key subgroups.

Generative artificial intelligence is a type of self-learning software that can increase the time pharmacists can allocate to patients, improve medication adherence, and allow patients to access health data on a whim.

Investigators aimed to determine whether liraglutide, an anti-obesity medication, could impact the learning process for individuals who had reduced insulin sensitivity due to obesity.

Patients with pancreatic cancer who took benzodiazepine lorazepam had a shorter progression-free survival than those who took benzodiazepine alprazolam.

Relapses of MIS-C occurred in 2 patients due to rapid tapering of corticosteroids at 2 weeks instead of the standard protocol of 4 to 6 weeks.

Following an increase in government seizures of ayahuasca, an Indigenous religious organization requested government records that led to these seizures. The DEA responded by sending a single report condemning use of the drug.

It is the first vaccine of its kind to be FDA approved, and it met multiple safety and efficacy standards through clinical trials.

Cases address questions about how to relieve dry eyes.

Zydus Pharmaceuticals (USA) Inc,. has come a long way since its first commercial launch in August 2005.

Pharmacy technicians should advocate for fair pay raises due to their crucial role, expanding skills, and cost-effectiveness over turnover.

On this episode, guests discuss how pharmacists can advocate for policy changes at the state level.

Sleep loss is known to impact key processes such as attention, cognition, learning, memory, metabolism, and immune function.

Researchers sought to find a remedy for the development of treatment-resistant depression in patients whose antidepressant treatment has fluctuated in efficacy.

The treatment is the first of its kind to be FDA-approved to treat CHAPLE disease.

“I've never met a pharmacist who didn't want to improve the health of the American people. That's what they're doing and will be doing well in the future,” Steven C. Anderson tells Pharmacy Times at NACDS TSE, August 12 through 14, 2023, San Diego, California.